AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Denali Therapeutics Statistics
Share Statistics
Denali Therapeutics has 143.92M shares outstanding. The number of shares has increased by 3.42% in one year.
Shares Outstanding | 143.92M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.53% |
Owned by Institutions (%) | n/a |
Shares Floating | 124.59M |
Failed to Deliver (FTD) Shares | 395 |
FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 7.46M, so 5.19% of the outstanding shares have been sold short.
Short Interest | 7.46M |
Short % of Shares Out | 5.19% |
Short % of Float | 5.99% |
Short Ratio (days to cover) | 8.62 |
Valuation Ratios
The PE ratio is -20.3 and the forward PE ratio is -10.87.
PE Ratio | -20.3 |
Forward PE | -10.87 |
PS Ratio | 8.92 |
Forward PS | 14.3 |
PB Ratio | 2.86 |
P/FCF Ratio | -7.95 |
PEG Ratio | n/a |
Enterprise Valuation
Denali Therapeutics Inc. has an Enterprise Value (EV) of 2.87B.
EV / Earnings | -19.78 |
EV / Sales | 8.69 |
EV / EBITDA | -15.96 |
EV / EBIT | -14.61 |
EV / FCF | -7.75 |
Financial Position
The company has a current ratio of 13.65, with a Debt / Equity ratio of 0.
Current Ratio | 13.65 |
Quick Ratio | 13.65 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0 |
Cash Flow / Debt | 0 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.14% and return on capital (ROIC) is -18.16%.
Return on Equity (ROE) | -0.14% |
Return on Assets (ROA) | -0.13% |
Return on Capital (ROIC) | -18.16% |
Revenue Per Employee | 847.52K |
Profits Per Employee | -372.37K |
Employee Count | 390 |
Asset Turnover | 0.29 |
Inventory Turnover | 0 |
Taxes
Income Tax | 30.00K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 2.12% in the last 52 weeks. The beta is 1.39, so Denali Therapeutics 's price volatility has been higher than the market average.
Beta | 1.39 |
52-Week Price Change | 2.12% |
50-Day Moving Average | 24.05 |
200-Day Moving Average | 23.08 |
Relative Strength Index (RSI) | 33.72 |
Average Volume (20 Days) | 880.29K |
Income Statement
In the last 12 months, Denali Therapeutics had revenue of 330.53M and earned -145.22M in profits. Earnings per share was -1.06.
Revenue | 330.53M |
Gross Profit | 313.81M |
Operating Income | -196.70M |
Net Income | -145.22M |
EBITDA | -179.97M |
EBIT | -196.70M |
Earnings Per Share (EPS) | -1.06 |
Balance Sheet
The company has 127.11M in cash and 52.24M in debt, giving a net cash position of 74.86M.
Cash & Cash Equivalents | 127.11M |
Total Debt | 52.24M |
Net Cash | 74.86M |
Retained Earnings | -1.12B |
Total Assets | 1.45B |
Working Capital | 781.75M |
Cash Flow
In the last 12 months, operating cash flow was -357.99M and capital expenditures -12.94M, giving a free cash flow of -370.93M.
Operating Cash Flow | -357.99M |
Capital Expenditures | -12.94M |
Free Cash Flow | -370.93M |
FCF Per Share | -2.7 |
Margins
Gross margin is 94.94%, with operating and profit margins of -59.51% and -43.94%.
Gross Margin | 94.94% |
Operating Margin | -59.51% |
Pretax Margin | -43.93% |
Profit Margin | -43.94% |
EBITDA Margin | -54.45% |
EBIT Margin | -59.51% |
FCF Margin | -112.22% |
Dividends & Yields
DNLI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -5.65% |
FCF Yield | -13.74% |
Analyst Forecast
The average price target for DNLI is $32, which is 70.6% higher than the current price. The consensus rating is "Buy".
Price Target | $32 |
Price Target Difference | 70.6% |
Analyst Consensus | Buy |
Analyst Count | 13 |
Scores
Altman Z-Score | 10.74 |
Piotroski F-Score | 2 |